Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
8th grade Avg
|
Filing tables
Filing exhibits
- 10-K Annual report
- 21.1 Subsidiaries of the Registrant
- 23.1 Consent of Deloitte & Touche LLP
- 31.1 Certification Pursuant to Rule 13A-14(A), President & Chief Executive Officer
- 31.2 Certification Pursuant to Rule 13A-14(A), Chief Financial Officer
- 32.1 Certification Pursuant to 18 U.s.c. Section, President & Chief Executive Officer
- 32.2 Certification Pursuant to 18 U.s.c. Section, Chief Financial Officer
GALT similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in Registration Statement Nos. 333-109887, 333-115118, 333-118907 and 333-116500 on Form S-3 and in Registration Statement Nos. 333-116629 and 333-109893 on Form S-8 of our report dated April 7, 2005, relating to the financial statements of Pro- Pharmaceuticals, Inc. appearing in this Annual Report on Form 10-K of Pro- Pharmaceuticals, Inc. for the year ended December 31, 2004.
/s/ Deloitte & Touche LLP
Boston, Massachusetts
April 7, 2005